NCT06299163 2025-07-23NM32-2668 in Adult Patients With Selected Advanced Solid TumorsNumab Therapeutics AGPhase 1 Terminated11 enrolled
NCT04099277 2021-08-31A Study of LY3435151 in Participants With Solid TumorsEli Lilly and CompanyPhase 1 Terminated2 enrolled 8 charts